In our study, 111In-DOTAGA-F(ab′)2-cetuximab was used as a diagnostic tool for colorectal cancer to follow the efficacy of a HER1 targeted therapy by the HSP90 inhibitor, 17-DMAG. The gene discussed is EGFR; the disease is colorectal cancer.